When to start bisphosphonate FRAX?
As a healthcare professional, I'm often faced with the question of when to initiate bisphosphonate therapy for fracture risk reduction, commonly referred to as FRAX. The decision is multifaceted, involving a thorough assessment of the patient's risk factors, including age, bone mineral density, fracture history, and comorbidities. Could you elaborate on the specific clinical scenario you're considering? For instance, is the patient a postmenopausal woman with osteoporosis? Or is it a male patient with low trauma fracture? Understanding the individual patient's characteristics will help determine the optimal timing for starting bisphosphonate FRAX.